These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21134077)

  • 81. TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability.
    Sim KG; Zang Z; Yang CM; Bonventre JV; Hsu SI
    Cell Cycle; 2004 Oct; 3(10):1296-304. PubMed ID: 15467469
    [TBL] [Abstract][Full Text] [Related]  

  • 82. KLF15 in breast cancer: a novel tumor suppressor?
    Yoda T; McNamara KM; Miki Y; Onodera Y; Takagi K; Nakamura Y; Ishida T; Suzuki T; Ohuchi N; Sasano H
    Cell Oncol (Dordr); 2015 Jun; 38(3):227-35. PubMed ID: 25869021
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice.
    Onoyama I; Nakayama KI
    Cell Cycle; 2008 Nov; 7(21):3307-13. PubMed ID: 18948752
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prognostic values of F-box members in breast cancer: an online database analysis and literature review.
    Wang X; Zhang T; Zhang S; Shan J
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30341246
    [No Abstract]   [Full Text] [Related]  

  • 85. Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells.
    Willmarth NE; Albertson DG; Ethier SP
    Breast Cancer Res; 2004; 6(5):R531-9. PubMed ID: 15318934
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer.
    Tőkés T; Tőkés AM; Szentmártoni G; Kiszner G; Mühl D; Molnár BÁ; Kulka J; Krenács T; Dank M
    Pathol Oncol Res; 2020 Jul; 26(3):1499-1510. PubMed ID: 31446607
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer.
    Jiang H; Wang B; Zhang F; Qian Y; Chuang CC; Ying M; Wang Y; Zuo L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801830
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
    Ben Abdelali R; Asnafi V; Leguay T; Boissel N; Buzyn A; Chevallier P; Thomas X; Lepretre S; Huguet F; Vey N; Escoffre-Barbe M; Tavernier E; Reman O; Fegueux N; Turlure P; Rousselot P; Cahn JY; Lheritier V; Chalandon Y; Béné MC; Macintyre E; Dombret H; Ifrah N;
    Blood; 2011 Nov; 118(19):5099-107. PubMed ID: 21835957
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinical Significance of
    Uhercik M; Sanders AJ; Owen S; Davies EL; Sharma AK; Jiang WG; Mokbel K
    Anticancer Res; 2017 Aug; 37(8):4249-4254. PubMed ID: 28739716
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Fbxw7 hotspot mutations and human colon cancer: mechanistic insights from new mouse models.
    Grim JE
    Gut; 2014 May; 63(5):707-9. PubMed ID: 24000292
    [No Abstract]   [Full Text] [Related]  

  • 91. The FBXW7 tumor suppressor inhibits breast cancer proliferation and promotes apoptosis by targeting MTDH for degradation.
    Chen X; Li XY; Long M; Wang X; Gao ZW; Cui Y; Ren J; Zhang Z; Liu C; Dong K; Zhang H
    Neoplasma; 2018; 65(2):201-209. PubMed ID: 29534580
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Croteau DL; Moseley PM; Hameed K; Green A; Aleskandarany MA; Rakha EA; Patterson K; Ball G; Chan SY; Ellis IO; Bohr VA; Bryant HE; Madhusudan S
    Carcinogenesis; 2016 Jan; 37(1):63-71. PubMed ID: 26586793
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fucosyltransferase 8 expression in breast cancer patients: A high throughput tissue microarray analysis.
    Yue L; Han C; Li Z; Li X; Liu D; Liu S; Yu H
    Histol Histopathol; 2016 May; 31(5):547-55. PubMed ID: 26596733
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The prognostic impact of some cell cycle regulatory proteins in Egyptian breast cancer patients.
    Kamel A; Mokhtar N; Elshakankiry N; Yassin D; Elnahass Y; Zakarya O; Elbasmy A; Elmetenawy W
    J Egypt Natl Canc Inst; 2006 Jun; 18(2):93-102. PubMed ID: 17496933
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
    Kurozumi S; Joseph C; Sonbul S; Aleskandarany MA; Pigera M; Alsaleem M; Alsaeed S; Kariri Y; Nolan CC; Diez-Rodriguez M; Johnston S; Mongan NP; Fujii T; Shirabe K; Martin SG; Ellis IO; Green AR; Rakha EA
    Breast Cancer Res Treat; 2018 Nov; 172(1):61-68. PubMed ID: 30056565
    [TBL] [Abstract][Full Text] [Related]  

  • 96. TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivity.
    Wennemers M; Bussink J; Grebenchtchikov N; Sweep FC; Span PN
    Radiother Oncol; 2011 Oct; 101(1):198-202. PubMed ID: 21704407
    [TBL] [Abstract][Full Text] [Related]  

  • 97. MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours.
    Green AR; Aleskandarany MA; Agarwal D; Elsheikh S; Nolan CC; Diez-Rodriguez M; Macmillan RD; Ball GR; Caldas C; Madhusudan S; Ellis IO; Rakha EA
    Br J Cancer; 2016 Apr; 114(8):917-28. PubMed ID: 26954716
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Constitutional de novo deletion of the FBXW7 gene in a patient with focal segmental glomerulosclerosis and multiple primitive tumors.
    Roversi G; Picinelli C; Bestetti I; Crippa M; Perotti D; Ciceri S; Saccheri F; Collini P; Poliani PL; Catania S; Peissel B; Pagni F; Russo S; Peterlongo P; Manoukian S; Finelli P
    Sci Rep; 2015 Oct; 5():15454. PubMed ID: 26482194
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation.
    Bengoechea-Alonso MT; Ericsson J
    Oncogene; 2010 Sep; 29(38):5322-8. PubMed ID: 20622901
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
    Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
    BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.